CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
zinc acetatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00004338
NCT00004338Phase 4Completed
CompareCT.gov

Study of Zinc for Wilson Disease

National Center for Research Resources (NCRR)·interventional·Posted Oct 19, 1999·Updated Jun 24, 2005

In Brief

A Phase 4 clinical trial evaluating zinc acetate for Wilson Disease. Completed, across 1 site.

Detailed Summary

OBJECTIVES: I. Establish the safety and efficacy of extended maintenance zinc therapy in 200 patients with Wilson disease. II. Establish further the role of zinc in the prophylactic treatment of presymptomatic patients by increasing the current cohort from 80 to at least 100 patients. III. Establish further the role of zinc therapy in pregnant patients with Wilson disease. IV. Establish further the role of zinc therapy in children with Wilson disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWilson Disease
CountriesUnited States
CollaboratorsUniversity of Michigan

Timeline

Phase 4CompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 19, 1999
Enrollment StartOct 1, 1993
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

zinc acetatedrug